Compare PAYX & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYX | HLN |
|---|---|---|
| Founded | 1979 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Business Services | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.8B | 42.8B |
| IPO Year | 1995 | 2021 |
| Metric | PAYX | HLN |
|---|---|---|
| Price | $119.00 | $9.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 1 |
| Target Price | ★ $111.67 | N/A |
| AVG Volume (30 Days) | 2.1M | ★ 8.4M |
| Earning Date | 03-25-2026 | 02-26-2026 |
| Dividend Yield | ★ 4.59% | 1.94% |
| EPS Growth | ★ 6.77 | N/A |
| EPS | ★ 4.89 | N/A |
| Revenue | ★ $6,512,000,000.00 | N/A |
| Revenue This Year | $19.19 | $6.55 |
| Revenue Next Year | $5.50 | $4.42 |
| P/E Ratio | ★ $24.89 | $49.05 |
| Revenue Growth | ★ 16.88 | N/A |
| 52 Week Low | $85.45 | $8.65 |
| 52 Week High | $135.97 | $11.28 |
| Indicator | PAYX | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 45.45 | 32.70 |
| Support Level | $118.48 | $9.30 |
| Resistance Level | $125.32 | $9.39 |
| Average True Range (ATR) | 2.40 | 0.14 |
| MACD | -0.99 | -0.07 |
| Stochastic Oscillator | 3.73 | 1.62 |
Paychex is a cloud-based human capital management provider offering payroll, compliance, talent management, benefits administration, and retirement services. The firm also provides HR outsourcing services, including professional employer organization, or PEO, offerings, enabling clients to reduce HR overhead. Paychex primarily targets small and midsize businesses, although its acquisition of Paycor in 2025 signals the firm's aspirations to expand into the midmarket segment, serving firms with more than 100 employees. As of fiscal 2026, Paychex has approximately 800,000 clients and manages payroll for one in 11 workers in the United States.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.